TRGT

February 13, 2014 Targacept Reports Fourth Quarter and 2013 Financial Results

[at noodls] – Targacept Reports Fourth Quarter and 2013 Financial Results February 13, 2014 Winston-Salem, North Carolina – Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

Targacept Reports Fourth Quarter and 2013 Financial Results

[Business Wire] – Targacept, Inc. , a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today reported its financial results for the fourth quarter and year moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

AstraZeneca returns several compounds to Targacept

moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

Targacept Announces Participation in Upcoming Conferences

[at noodls] – Winston-Salem, NC April 22, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today announced that Dr. Stephen A. Hill, President and Chief … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619

[at noodls] – Winston-Salem, North Carolina April 18, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today announced that it has completed recruitment … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

Targacept to Present at the 15th Annual BIO CEO & Investor Conference

[at noodls] – Winston-Salem, North Carolina February 04, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboardSee who Targacept is hiring next, click here to view […]

Targacept to Present at the 2012 Deutsche Bank dbAccess BioFEST

[at noodls] – Winston-Salem, NC November 27, 2012 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that members of its executive management … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboard […]

Targacept Reports Third Quarter 2012 Financial Results

[at noodls] – Winston-Salem, North Carolina November 06, 2012 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today reported its financial results for the … moreView todays social media effects on TRGTView the latest stocks trending across Twitter. Click to view dashboard […]